Table 3.

Linear regression analysis for evaluation of association of CIMT, FMD and ABI with different parameters in diabetic and non-diabetic subjects

Variable	CIMT		FMD		ABI
	Non diabetic β, (P)§	Diabetic β, (P)§	Non diabetic β, (P)§	Diabetic β, (P)§	Non diabetic β, (P)§	Diabetic β, (P)§
Age	0.33 (0.01)	0.31 (0.01)	-0.23 (0.02)	-0.15 (0.12)	0.19 (0.04)	-0.09 (0.36)
Sex	-0.12 (0.2)	-0.23 (0.01)	0.09 (0.38)	0.19 (0.06)	0.03 (0.73)	-0.16 (0.1)
Systolic BP	0.27 (0.01)	0.14 (0.12)	0.32 (0.01)	-0.04 (0.72)	-0.01 (0.31)	0.03 (0.8)
Diastolic BP	0.22 (<0.01)	0.19 (0.03)	-0.13 (0.19)	-0.05 (0.61)	-0.16 (0.08)	0.06 (0.54)
BMI	-0.07 (0.45)	-0.21 (0.04)	-0.13 (0.2)	-0.05 (0.65)	0.20 (0.04)	0.01 (0.94)
Waist circumference	-0.001 (0.98)	-0.24 (0.01)	0.05 (0.64)	0.04 (0.70)	0.11 (0.28)	0.00 (0.99)
HOMA IR	-0.02 (0.78)	-0.12 (0.2)	-0.17 (0.09)	0.00 (1.00)	0.02 (0.81)	-0.03 (0.75)
Hs-CRP	-0.01 (0.95)	0.00 (0.97)	-0.16 (0.1)	0.10 (0.37)	-0.15 (0.09)	-0.09 (0.33)
IL-6	0.18 (0.03)	-0.07 (0.43)	-0.20 (0.81)	0.13 (0.21)	-0.15 (0.11)	0.08 (0.43)

BMI = body mass index; BP = blood pressure; HOMA IR = Homeostatic model assessment; hs- CRP = high sensitive C-reactive protein; IL-6 = interleukin 6; CIMT = Carotid Intima Media thickness; FMD = flow Mediated Dilatation; ABI = Ankle - brachial index. §: adjusted for age, sex, triglyceride, total cholesterol, HDL-C and LDL-C.